Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
Apyx Medical Corporation (NASDAQ:APYX), a manufacturer of advanced helium plasma and radiofrequency technology, will release its Q2 2025 financial results on August 7, 2025, after market close. The company will host a conference call at 4:30 PM ET the same day.
Apyx Medical specializes in the 搁别苍耻惫颈辞苍庐 and AYON Body Contouring System鈩� for the cosmetic surgery market, and 闯-笔濒补蝉尘补庐 for hospital surgical applications. Their technology's effectiveness is backed by over 90 clinical publications, demonstrating their strong presence in the advanced energy technology sector.
Apyx Medical Corporation (NASDAQ:APYX), produttrice di tecnologie avanzate a plasma di elio e radiofrequenza, pubblicher脿 i suoi risultati finanziari del secondo trimestre 2025 il 7 agosto 2025, dopo la chiusura dei mercati. La societ脿 terr脿 una conference call lo stesso giorno alle 16:30 ET.
Apyx Medical 猫 specializzata nel sistema 搁别苍耻惫颈辞苍庐 e AYON Body Contouring System鈩� per il mercato della chirurgia estetica, e in 闯-笔濒补蝉尘补庐 per applicazioni chirurgiche ospedaliere. L鈥檈fficacia della loro tecnologia 猫 supportata da oltre 90 pubblicazioni cliniche, a testimonianza della loro solida presenza nel settore delle tecnologie energetiche avanzate.
Apyx Medical Corporation (NASDAQ:APYX), fabricante de tecnolog铆a avanzada de plasma de helio y radiofrecuencia, publicar谩 sus resultados financieros del segundo trimestre de 2025 el 7 de agosto de 2025, despu茅s del cierre del mercado. La compa帽铆a realizar谩 una llamada conferencia el mismo d铆a a las 4:30 PM ET.
Apyx Medical se especializa en el sistema 搁别苍耻惫颈辞苍庐 y AYON Body Contouring System鈩� para el mercado de cirug铆a est茅tica, y en 闯-笔濒补蝉尘补庐 para aplicaciones quir煤rgicas hospitalarias. La efectividad de su tecnolog铆a est谩 respaldada por m谩s de 90 publicaciones cl铆nicas, demostrando su fuerte presencia en el sector de tecnolog铆a energ茅tica avanzada.
Apyx Medical Corporation (NASDAQ:APYX)電� 觳嫧 項エ 頂岆澕歃堧 氚� 瓿犾＜韺� 旮办垹 鞝滌“鞐呾泊搿�, 2025雲� 8鞗� 7鞚� 鞛� 毵堦皭 頉� 2025雲� 2攵勱赴 鞛 鞁れ爜鞚� 氚滍憸頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� 臧欖潃 雮� 鞓ろ泟 4鞁� 30攵� ET鞐� 旎嵓霟办姢 旖滌潉 歆勴枆頃╇媹雼�.
Apyx Medical鞚� 氙胳毄 靾橃垹 鞁滌灔鞚� 鞙勴暅 搁别苍耻惫颈辞苍庐 氚� AYON Body Contouring System鈩㈥臣 氤戩洂 靾橃垹鞖� 闯-笔濒补蝉尘补庐毳� 鞝勲鞙茧 頃╇媹雼�. 鞚措摛鞚� 旮办垹 須臣電� 90瓯� 鞚挫儊鞚� 鞛勳儊 雲茧鞙茧 霋冯皼旃悩鞏� 觳嫧 鞐愲剤歆� 旮办垹 攵勳暭鞐愳劀 臧曤牓頃� 鞛呾毳� 氤挫棳欷嶋媹雼�.
Apyx Medical Corporation (NASDAQ:APYX), fabricant de technologies avanc茅es au plasma d鈥檋茅lium et 脿 radiofr茅quence, publiera ses r茅sultats financiers du deuxi猫me trimestre 2025 le 7 ao没t 2025, apr猫s la cl么ture des march茅s. La soci茅t茅 tiendra une conf茅rence t茅l茅phonique le m锚me jour 脿 16h30 ET.
Apyx Medical est sp茅cialis茅e dans le syst猫me 搁别苍耻惫颈辞苍庐 et AYON Body Contouring System鈩� pour le march茅 de la chirurgie esth茅tique, ainsi que dans 闯-笔濒补蝉尘补庐 pour les applications chirurgicales hospitali猫res. L鈥檈fficacit茅 de leur technologie est soutenue par plus de 90 publications cliniques, d茅montrant leur forte pr茅sence dans le secteur des technologies 茅nerg茅tiques avanc茅es.
Apyx Medical Corporation (NASDAQ:APYX), ein Hersteller von fortschrittlicher Heliumplasma- und Radiofrequenztechnologie, wird seine Finanzergebnisse f眉r das zweite Quartal 2025 am 7. August 2025 nach B枚rsenschluss ver枚ffentlichen. Das Unternehmen veranstaltet am selben Tag um 16:30 Uhr ET eine Telefonkonferenz.
Apyx Medical ist spezialisiert auf das 搁别苍耻惫颈辞苍庐 und AYON Body Contouring System鈩� f眉r den kosmetischen Chirurgiemarkt sowie 闯-笔濒补蝉尘补庐 f眉r chirurgische Anwendungen im Krankenhaus. Die Wirksamkeit ihrer Technologie wird durch 眉ber 90 klinische Ver枚ffentlichungen belegt, was ihre starke Pr盲senz im Bereich der fortschrittlichen Energietechnologie unterstreicht.
- None.
- None.
CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (鈥淎pyx Medical;鈥� the 鈥淐ompany鈥�), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion庐 and the AYON Body Contouring System鈩�, today announced that financial results for the second quarter of fiscal year 2025 will be released after markets closes on Thursday, August 7th.
Management will host a conference call at 4:30 p.m. Eastern Time on Thursday, August 7th, to discuss the results of the quarter, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 35370. Participants should ask for the 鈥淎pyx Medical Corporation Call鈥�. A live webcast of the call will be accessible via the following link:聽聽and via the聽聽of the Company鈥檚 website, where it will also be archived for future reference.
Investor Relations Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
OP: 212-915-2568
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people鈥檚 lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion庐 and now the AYON Body Contouring System鈩� in the cosmetic surgery market and J-Plasma庐聽in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at聽
FAQ
When will Apyx Medical (NASDAQ:APYX) release Q2 2025 earnings?
How can investors access Apyx Medical's Q2 2025 earnings call?
What are the main products of Apyx Medical Corporation?
How many clinical publications support Apyx Medical's technology?
